Fastlane Launches AI Marketing Platform That Researches, Creates and Runs Campaigns End to End CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
First Study from CANbridge UMass Collaboration Shows Novel Gene Therapy Holds Promise for Spinal Muscular…
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Upstart Holdings, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of…
Innovative Industrial Properties Acquires Massachusetts Property and Enters Into Long-Term Lease with TILT
SAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on…
ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
FREMONT, CA, May 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire—ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical…
Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
AV-101 is being developed to address cellular hyperproliferation and resistance to apoptosis in the pulmonary…
Preclinical Proof-of-Concept Data Supporting Future Clinical Development of Two New Cell Therapies Being Presented by Adaptimmune at ASGCT
– New next-gen SPEAR T-cells (ADP-A2M4N7X19) designed to enhance depth and durability of clinical response…
AnPac Bio Reports Fiscal Year 2021 Annual Financial Results
PHILADELPHIA, May 16, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company”…
Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) — Petros Pharmaceuticals, Inc. (“Petros” or “the Company”)…
Athira Issues Statement in Response to Richard A. Kayne’s Suspension of His Proxy Contest
Athira Board Unanimously Recommends Shareholders Vote “FOR” its Highly Qualified Nominees – Joseph Edelman, John…
NightHawk Biosciences Provides First Quarter 2022 Business Update
DURHAM, N.C., May 16, 2022 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK), a fully…
Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Management to host webcast/conference call today at 2 p.m. PT / 5 p.m. ET SAN…
Biora Therapeutics to Participate in Upcoming H.C. Wainwright Global Investment Conference
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…
Sanara MedTech Inc. Announces First Quarter 2022 Results
FORT WORTH, TX , May 16, 2022 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the…
The Greenrose Holding Company Reports First Quarter 2022 Results
Focus on Optimizing Inventory in Connecticut and Production Capacity in Arizona Improving Positioning for Early-Stage…
Healthy Extracts Reports 172% Revenue Growth and Positive Net Income in First Quarter 2022
LAS VEGAS, May 16, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading…
Homology Medicines Reports First Quarter 2022 Financial Results and Recent Highlights
– $130 Million in Non-Dilutive Capital Strengthened Financial Position – – Presentations at Upcoming ASGCT…
IO Biotech Announces First Quarter Results for 2022
— Updated Data from Phase 1/2 study of IO102-IO103 in Combination with Nivolumab Showing High…
Agios Announces Evolution of Research Organization
– Sarah Gheuens, M.D., Ph.D., to be Named Head of R&D, Chief Medical Officer; Chief…
Celularity Reports First Quarter 2022 Financial Results and Provides Corporate Update
Ongoing Phase 1 study of unmodified placental-derived natural killer (NK) cell therapy candidate, CYNK-001, in…
Ayala Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Interim data from Part A of RINGSIDE study of AL102 expected mid-2022 REHOVOT, Israel and…